论文部分内容阅读
目的探讨醒脑静注射液联合脑蛋白水解物治疗急性脑梗死的影响。方法符合诊断标准的急性脑梗死病例90例,随机分为观察组和对照组,各45例。对照组单纯予常规治疗加脑蛋白水解物,观察组在对照组治疗基础上,加用醒脑静治疗2周,4周后观察疗效与不良反应。结果观察组45例中基本痊愈25例(55.56%),显效10例(22.22%),有效5例(11.11%),总有效率88.89%;对照组45例中基本痊愈16例(35.56%),显效8例(17.78%),有效4例(8.89%),总有效率62.22%,观察组与对照组在治疗缺血性脑卒中疗效方面比较有统计学意义(P<0.05)。结论醒脑静联合脑蛋白水解物治疗急性脑梗死明显优于对照组。
Objective To investigate the effect of xingnaojing injection combined with brain protein hydrolyzate in the treatment of acute cerebral infarction. Methods 90 cases of acute cerebral infarction meeting the diagnostic criteria were randomly divided into observation group and control group, with 45 cases in each group. The control group was given routine treatment plus brain hydrolyzate. The observation group was treated with XNZ for 2 weeks and the observation group was 4 weeks after the treatment. The curative effect and side effects were observed. Results The observation group was basically cured in 25 cases (55.56%), markedly effective in 10 cases (22.22%), effective in 5 cases (11.11%), the total effective rate was 88.89%; control group of 45 cases basically recovered in 16 cases (35.56% , Markedly effective in 8 cases (17.78%), effective in 4 cases (8.89%) and total effective rate of 62.22%. The observation group and the control group were statistically significant in the treatment of ischemic stroke (P <0.05). Conclusion Xingnaojing combined with brain protein hydrolyzate treatment of acute cerebral infarction was significantly better than the control group.